The oncoarray consortium: A network for understanding the genetic architecture of common cancers

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 1, 2017, Pages 126-135

  Amos, Christopher I ^a   Dennis, Joe ^b   Wang, Zhaoming ^c   Byun, Jinyoung ^a   Schumacher, Fredrick R ^d   Gayther, Simon A ^e   Casey, Graham ^f   Hunter, David J ^g   Sellers, Thomas A ^h   Gruber, Stephen B ^f   Dunning, Alison M ^b   Michailidou, Kyriaki ^b   Fachal, Laura ^b   Doheny, Kimberly ⁱ   Spurdle, Amanda B ^j   Li, Yafang ^a   Xiao, Xiangjun ^a   Romm, Jane ⁱ   Pugh, Elizabeth ⁱ   Coetzee, Gerhard A ^k   Hazelett, Dennis J ^e   Bojesen, Stig E ^l   Caga Anan, Charlisse ^m   Haiman, Christopher A ^e   Kamal, Ahsan ^a   Luccarini, Craig ^b   Tessier, Daniel ⁿ   Vincent, Daniel ⁿ   Bacot, Francois ⁿ   Van Den Berg, David J ^f   Nelson, Stefanie ^m   Demetriades, Stephen ^o   Goldgar, David E ^p   Couch, Fergus J ^q   Forman, Judith L ^a   Giles, Graham G ^r,s   Conti, David V ^f   Bickeboller, Heike ^t   Risch, Angela ^u,y,at   Waldenberger, Melanie ^v   Bruske Hohlfeld, Irene ^v   Hicks, Belynda D ^w   Ling, Hua ⁱ   McGuffog, Lesley ^r,s   Lee, Andrew ^b   Kuchenbaecker, Karoline ^b   Soucy, Penny ^x   Manz, Judith ^v   Cunningham, Julie M ^q   Butterbach, Katja ^y   Kote Jarai, Zsofia ^z   Kraft, Peter ^g   FitzGerald, Liesel ^r,s   Lindstrom, Sara ^g,aa   Adams, Marcia ⁱ   McKay, James D ^ab   Phelan, Catherine M ^h   Benlloch, Sara ^b   Kelemen, Linda E ^ac   Brennan, Paul ^ab   Riggan, Marjorie ^ad   O'Mara, Tracy A ^j   Shen, Hongbing ^ae   Shi, Yongyong ^af   Thompson, Deborah J ^b   Goodman, Marc T ^e   Nielsen, Sune F ^l   Berchuck, Andrew ^ad   Laboissiere, Sylvie ⁿ   Schmit, Stephanie L ^h   Shelford, Tameka ⁱ   Edlund, Christopher K ^f   Taylor, Jack A ^ag   Field, John K ^ah   Park, Sue K ^ai   Offit, Kenneth ^aj,ak,al   Thomassen, Mads ^am   Schmutzler, Rita ^an   Ottini, Laura ^ao   Hung, Rayjean J ^ap   Marchini, Jonathan ^aq   Olama, Ali Amin Al ^b   Peters, Ulrike ^ar   Eeles, Rosalind A ^z   Seldin, Michael F ^as   Gillanders, Elizabeth ^m   Seminara, Daniela ^m   Antoniou, Antonis C ^b   Pharoah, Paul D P ^b   Chenevix Trench, Georgia ^j   Chanock, Stephen J ^m   Simard, Jacques ^x   Easton, Douglas F ^b   more..

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^k VAN ANDEL RESEARCH INSTITUTE   (United States)

^l GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^m NATIONAL CANCER INSTITUTE   (United States)

ⁿ MCGILL UNIVERSITY   (Canada)

^o PRINCESS MARGARET HOSPITAL   (Canada)

^p UNIVERSITY OF UTAH   (United States)

^q MAYO CLINIC   (United States)

^r CANCER EPIDEMIOLOGY CENTRE   (Australia)

^s UNIVERSITY OF TASMANIA   (Australia)

^t UNIVERSITY OF GÖTTINGEN   (Germany)

^u UNIVERSITY OF SALZBURG   (Austria)

^v INSTITUTE OF EPIDEMIOLOGY   (Germany)

^w FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^x LAVAL UNIVERSITY   (Canada)

^y GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^z INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^aa UNIVERSITY OF WASHINGTON   (United States)

^ab INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ac MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^ad DUKE UNIVERSITY MEDICAL CENTER   (United States)

^ae NANJING MEDICAL UNIVERSITY   (China)

^af SHANGHAI JIAO TONG UNIVERSITY   (China)

^ag NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^ah UNIVERSITY OF LIVERPOOL   (United Kingdom)

^ai Seoul National University   (South Korea)

^aj Memorial Hospital   (United States)

^ak MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^al WEILL CORNELL MEDICAL COLLEGE   (United States)

^am ODENSE UNIVERSITY HOSPITAL   (Denmark)

^an UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^ao SAPIENZA UNIVERSITY OF ROME   (Italy)

^ap MOUNT SINAI HOSPITAL   (Canada)

^aq UNIVERSITY OF OXFORD   (United Kingdom)

^ar Fred Hutchinson Cancer Research Center   (United States)

^as UNIVERSITY OF CALIFORNIA   (United States)

^at Member of the German Center for Lung Research   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER GENETICS; CHINESE; CONTROLLED STUDY; DNA MICROARRAY; EQUIPMENT DESIGN; EUROPEAN; GENE STRUCTURE; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE MAP; HUMAN; JAPANESE (PEOPLE); MALIGNANT NEOPLASM; MEASUREMENT ACCURACY; MICROARRAY ANALYSIS; ONCOARRAY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENETIC SELECTION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; NEOPLASM; PATHOPHYSIOLOGY; PREVALENCE; PROCEDURES; PROGNOSIS; RISK ASSESSMENT;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SELECTION, GENETIC;

EID: 85009110706     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0106     Document Type: Article

References (82)

1. International WCRF. Lung cancer statistics; 2012 [cited 2015 May 2]. Available from: http://www.wcrf.org/int/cancer-facts-figures/data-specificcancers/lung-cancer-statistics.
2. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 1999;21:56-60.
3. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265:2037-48.
4. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502-10.
5. Houlston RS, Peto J. The search for low-penetrance cancer susceptibility alleles. Oncogene 2004;23:6471-6.
6. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI. Shifting paradigm of association studies: value of rare single nucleotide polymorphisms. Genet Epidemiol 2007;31:608.
7. Zhu Q, Ge D, Maia JM, Zhu M, Petrovski S, Dickson SP, et al. A genomewide comparisonof the functional properties of rare and common genetic variants in humans. Am J Hum Genet 2011;88:458-68.
8. Ponder BA. Inherited predisposition to cancer. Trends Genet 1990; 6:213-8.
9. Ponder BA. Cancer genetics. Nature 2001;411:336-41.
10. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-5.
11. Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet 2005;6:287-98.
12. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
13. Thomas DC. Statistical methods in genetic epidemiology. New York, NY: Oxford University Press; 2004.
14. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009;106:9362-7.
15. Qian DC, Byun J, Han Y, Hunter DJ, Henderson BE, Eeles R, et al. Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. Hum Mol Genet 2015;24:7406-20.
16. Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
17. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-Associated variation in regulatory DNA. Science 2012;337:1190-5.
18. Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, et al. Cell-Type-specific enrichment of risk-Associated regulatory elements at ovarian cancer susceptibility loci. Hum Mol Genet 2015;24:3595-607.
19. Hazelett DJ, Rhie SK, Gaddis M, Yan C, Lakeland DL, Coetzee SG, et al. Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet 2014;10:e1004102.
20. Smemo S, Tena JJ, Kim KH, Gamazon ER, SakabeNJ, Gomez-Marin C, et al. Obesity-Associated variants within FTO form long-range functional connections with IRX3. Nature 2014;507:371-5.
21. Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, et al. 8q24 prostate, breast, and colon cancer risk loci show tissuespecific long-range interaction with MYC. Proc Natl Acad Sci USA 2010;107:9742-6.
22. Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T, et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 2011;43:451-4.
23. Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, et al. Finemapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum Mol Genet 2015;24:1478-92.
24. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, et al. Epigenetic analysis leads to identification of HNF1B as a subtypespecific susceptibility gene for ovarian cancer. Nat Commun 2013; 4:1628.
25. Soslow RA. Histologic subtypes of ovarian carcinoma: An overview. Int J Gynecol Pathol 2008;27:161-74.
26. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies. Lancet Oncol 2012;13:385-94.
27. The Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497:67-73.
28. Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, et al. CYP19A1 fine-mapping andMendelian randomization: estradiol is causal for endometrial cancer. Endocr Relat Cancer 2016;23:77-91.
29. O'Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J, Australian National Endometrial Cancer Study Group, et al. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocr Relat Cancer 2015;22:851-61.
30. Bahcall OG. iCOGS collection provides a collaborative model. Foreword. Nat Genet 2013;45:343.
31. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013;45:371-84.
32. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385-91.
33. Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, et al. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers. J Natl Cancer Inst. 2015;108(2): pii: djv315.
34. Timofeeva MN, Hung RJ, Rafnar T, Christiani DC, Field JK, Bickeboller H, et al. Influence of common genetic variation on lung cancer risk: metaanalysis of 14 900 cases and 29 485 controls. Hum Mol Genet 2012;21:4980-95.
35. Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 2014;46:736-41.
36. Wang Y, Wei Y, Gaborieau V, Shi J, Han Y, Timofeeva MN, et al. Deciphering associations for lung cancer risk through imputation and analysis of 12 316 cases and 16 831 controls. Eur J Hum Genet 2015;23:1723-8.
37. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, et al. A meta-Analysis of 87, 040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 2014;46:1103-9.
38. Kachuri L, Amos CI, McKay JD, JohanssonM, Vineis P, Bueno-de-Mesquita HB, et al. Finemapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci. Carcinogenesis 2016;37:96-105.
39. Liu Y, Kheradmand F, Davis CF, Scheurer ME, Wheeler D, Tsavachidis S, et al. Focused analysis of exome sequencing data for rare germline mutations in familial and sporadic lung cancer. J Thorac Oncol 2016;11:52-61.
40. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, et al. A catalog of published genome-wide association studies [cited 2016 May 2]. Available from: https://www.genome.gov/26525384/catalog-of-published-genomewide-Association-studies/.
41. Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget 2016;7:7381-9.
42. Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun 2015;6:8234.
43. Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, et al. GWASmeta-Analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013;45:362-70.
44. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013;45:353-61.
45. Burdett T, Hall PN, Hastings E, Hindorff LA, Junkins HA, Klemm AK, et al. The NHGRI-EBI Catalog of published genome-wide association studies. Available from: www.ebi.ac.uk/gwas.
46. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007;39:977-83.
47. Yang J, Ferreira T, Morris AP, Medland SE, Genetic Investigation of Anthropometric Traits (GIANT) Consortium; DIAbetes Genetics Replication And Meta-Analysis (DIAGRAM) Consortium, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet 2013;44:369-75.
48. Cousminer DL, Stergiakouli E, Berry DJ, Ang W, Groen-Blokhuis MM, Korner A, et al. Genome-wide association study of sexual maturation in males and females highlights a role for body mass and menarche loci in male puberty. Hum Mol Genet 2014;23:4452-64.
49. Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ. Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet 2013;14:23-34.
50. Li Y, Byun J, Cai G, Xiao X, Han Y, Cornelis O, et al. FastPop: A rapid principal component derived method to infer intercontinental ancestry using genetic data. BMC Bioinformatics 2016;17:122.
51. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012;8:e1002793.
52. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011;13:101.
53. Holtzman NA, Marteau TM. Will genetics revolutionize medicine?NEngl J Med 2000;343:141-4.
54. Vineis P, Schulte P, McMichael AJ.Misconceptions about the use of genetic tests in populations. Lancet 2001;357:709-12.
55. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
56. Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, et al. Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genet Med 2015;17:789-95.
57. So HC, Kwan JS, Cherny SS, Sham PC. Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening. Am J Hum Genet 2011;88:548-65.
58. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008;322:881-8.
59. Hunter DJ, Altshuler D, Rader DJ. From Darwin's finches to canaries in the coal mine-mining the genome for new biology. N Engl J Med 2008; 358:2760-3.
60. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011;470:187-97.
61. Collins FS, Manolio TA. Merging and emerging cohorts: necessary but not sufficient. Nature 2007;445:259.
62. Khoury MJ, Wacholder S. Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies-challenges and opportunities. Am J Epidemiol 2009;169:227-30.
63. Manolio TA, Collins FS. Genes, environment, health, and disease: facing up to complexity. Hum Hered 2007;63:63-6.
64. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010;11:259-72.
65. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health 2010;31:21-36.
66. Evans DM, Marchini J, Morris AP, Cardon LR. Two-stage two-locus models in genome-wide association. PLoS Genet 2006;2:e157.
67. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 2005; 37:413-7.
68. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011;43:513-8.
69. Spisak S, Lawrenson K, Fu Y, Csabai I, Cottman RT, Seo JH, et al. CAUSEL: An epigenome-And genome-editing pipeline for establishing function of noncoding GWAS variants. Nat Med 2015;21:1357-63.
70. Shi J, Marconett CN, Duan J, Hyland PL, Li P, Wang Z, et al. Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nat Commun 2014;5:3365.
71. Scherf DB, Sarkisyan N, Jacobsson H, Claus R, Bermejo JL, Peil B, et al. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene 2013;32:3329-38.
72. Thurman RE, Rynes E, Humbert R, Vierstra J, MauranoMT, Haugen E, et al. The accessible chromatin landscape of the human genome. Nature 2012;489:75-82.
73. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell-Typespecific gene expression. Nature 2009;459:108-12.
74. Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 2013;342:253-7.
75. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008;4:e1000214.
76. Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, Ingle CE, et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet 2012;8:e1002639.
77. Burke W, Laberge AM, Press N. Debating clinical utility. Public Health Genomics 2010;13:215-23.
78. Kwan T, Grundberg E, Koka V, Ge B, Lam KC, Dias C, et al. Tissue effect on genetic control of transcript isoform variation. PLoS Genet 2009;5: e1000608.
79. Lalonde E, Ha KC, Wang Z, Bemmo A, Kleinman CL, Kwan T, et al. RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression. Genome Res 2011;21:545-54.
80. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M. Mapping complex disease traits with global gene expression. Nat Rev Genet 2009;10:184-94.
81. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 2013;152:633-41.
82. Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proc Natl Acad Sci USA 2012;109:11252-7.